Literature DB >> 21735389

WITHDRAWN: Written individualised management plans for asthma in children and adults.

Brett Toelle1, Felix Sf Ram.   

Abstract

BACKGROUND: Non-adherence to treatment advice is a common phenomenon in asthma and may account for a significant proportion of the morbidity. Comprehensive care that includes asthma education, a written self-management plan and regular review has been shown to improve asthma outcomes, but the contribution of these components has not been established.
OBJECTIVES: To determine whether the provision of a written asthma self-management plan increases adherence and improves outcome. SEARCH STRATEGY: We carried out a search on the Cochrane Airways Group trials register. There was no language restriction. The search of the databases used the following terms: action plan OR self OR self-care OR self-manag* OR educ* AND adher* OR comply OR compli*. We contacted authors of included studies for any unpublished or on-going studies and bibliographies of all included studies and reviews were searched for further studies. The most recent search was carried out in June 2004. SELECTION CRITERIA: We only considered randomised controlled trials (RCTs) in patients with asthma. Participants must have been assigned to receive an individualised written asthma management plan (symptom or peak flow based) about the actions required for regular asthma management and/or the actions to take in the event of an asthma exacerbation. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed study quality and abstracted data. MAIN
RESULTS: Seven trials met the inclusion criteria. The written management plans were either peak flow or symptom based, which were compared against each other or compared to no written management plan. Reported outcomes included: medication adherence, hospitalisation, emergency department visits, oral corticosteroid use, lung function, days lost from school/work, unscheduled doctor visits and respiratory tract infections. There was no consistent evidence that written plans produced better patient outcomes than no written plan. For some outcomes, there appeared to be an advantage of one type of plan over the other, but there was no consistency - one type of plan was not consistently more effective than another. AUTHORS'
CONCLUSIONS: The available trials are too small and the results too few and inconsistent to form any firm conclusions as to the contribution of written self management plans in the known beneficial effects of a comprehensive asthma care programme.

Entities:  

Mesh:

Year:  2011        PMID: 21735389     DOI: 10.1002/14651858.CD002171.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  5 in total

1.  Effective management of childhood asthma: pediatricians need to go the extra mile!

Authors:  Joseph L Mathew
Journal:  Indian J Pediatr       Date:  2013-06-15       Impact factor: 1.967

Review 2.  Personalised asthma action plans for adults with asthma.

Authors:  Timothy L Gatheral; Alison Rushton; David Jw Evans; Caroline A Mulvaney; Nathan R Halcovitch; Gemma Whiteley; Fiona Jr Eccles; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2017-04-10

Review 3.  The economics of medicines optimization: policy developments, remaining challenges and research priorities.

Authors:  Rita Faria; Marco Barbieri; Kate Light; Rachel A Elliott; Mark Sculpher
Journal:  Br Med Bull       Date:  2014-09       Impact factor: 4.291

4.  Supporting patients self-managing respiratory health: a qualitative study on the impact of the Breathe Easy voluntary group network.

Authors:  Ferhana Hashem; Rowena Merritt
Journal:  ERJ Open Res       Date:  2018-02-09

Review 5.  Barriers and facilitators of effective self-management in asthma: systematic review and thematic synthesis of patient and healthcare professional views.

Authors:  Clare Miles; Emily Arden-Close; Mike Thomas; Anne Bruton; Lucy Yardley; Matthew Hankins; Sarah E Kirby
Journal:  NPJ Prim Care Respir Med       Date:  2017-10-09       Impact factor: 2.871

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.